Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Wockhardt Ltd slips for fifth straight session
Wockhardt Ltd is quoting at Rs 1936.7, down 0.67% on the day as on 13:19 IST on the NSE. The stock jumped 87.69% in last one year as compared to a 6.32% slide in NIFTY and a 15.05% spurt in the Nifty Pharma index.
Jyotivardhan Jaipuria stays overweight on banks and pharma, avoids large IT for now
Jyotivardhan Jaipuria, Founder & MD of Valentis Advisors, remains positive on banks, citing strong credit growth, improving net interest margins and attractive valuations despite recent senior management changes across private lenders. He also continues to favour pharma, particularly US generics and CDMOs, on easing pricing pressure and China-plus-one opportunities. Jaipuria stays underweight on large IT, saying acquisitions may take time to deliver, while preferring select auto ancillaries with domestic, EV, defence and aerospace exposure.
Healthcare, banks and EVs remain long-term bets: Invesco Mutual Fund's Taher Badshah
Taher Badshah, Chief Investment Officer at Invesco Mutual Fund, expects EV adoption to increase gradually with policy support, while opportunities are emerging in power distribution alongside transmission. Badshah also said SIP inflows remain stable and mutual fund industry trends are not showing signs of concern.
Cipla Ltd soars 2.53%, up for fifth straight session
Cipla Ltd is quoting at Rs 1476.6, up 2.53% on the day as on 12:44 IST on the NSE. The stock is down 1.95% in last one year as compared to a 6.16% drop in NIFTY and a 14.71% drop in the Nifty Pharma.
HDFC Mutual Fund buys additional 10 lakh shares of Global Health for Rs 130 crore
HDFC Mutual Fund has secured an additional 10 lakh shares of Global Health, which is known for operating Medanta hospitals, from co-founder Sunil Sachdeva for Rs 130 crore. This acquisition builds on a prior purchase made last month. The transaction accounts for a 0.37% stake in the company. In related news, Global Health has reported an impressive 39.7% increase in its fourth-quarter profit after tax, totaling Rs 141.7 crore.
Stocks to buy or sell: Osho Krishan of Angel One suggests buying HDFC Bank, Emcure Pharma shares on 25 June - Mint
Stocks to buy or sell: Osho Krishan of Angel One suggests buying HDFC Bank, Emcure Pharma shares on 25 JuneMint
Ipca Laboratories Ltd spurts 0.16%, up for fifth straight session
Ipca Laboratories Ltd is quoting at Rs 1627.6, up 0.16% on the day as on 12:44 IST on the NSE. The stock is up 19.88% in last one year as compared to a 4.96% jump in NIFTY and a 15.12% jump in the Nifty Pharma.
Tech-Led global selloff, Fed rate fears weigh on Indian equities
Indian stock markets experienced their sharpest single-day drop in nearly a month, mirroring a global tech sell-off. The Nifty 50 and BSE Sensex both fell significantly, influenced by a strong US dollar and profit-taking after recent gains. While pharma and healthcare sectors showed resilience, most others, including metals and IT, declined. Market volatility increased, with analysts watching key support levels closely.
Laurus Labs Ltd soars 2.73%, Gains for third straight session
Laurus Labs Ltd is quoting at Rs 1475.1, up 2.73% on the day as on 12:49 IST on the NSE. The stock is up 120.31% in last one year as compared to a 4.46% fall in NIFTY and a 15.59% fall in the Nifty Pharma index.
Sun Pharmaceutical Industries Ltd spurts 1.19%, rises for fifth straight session
Sun Pharmaceutical Industries Ltd is quoting at Rs 1885, up 1.19% on the day as on 12:44 IST on the NSE. The stock is up 13.44% in last one year as compared to a 4.38% drop in NIFTY and a 15.7% drop in the Nifty Pharma.
39 NIFTY 500 stocks that delivered consistent growth over 5 years; Natco Pharma, ABB, M&M among top picks - Upstox
39 NIFTY 500 stocks that delivered consistent growth over 5 years; Natco Pharma, ABB, M&M among top picksUpstox
Market snaps five-day rally as IT rout drags Nifty below 24,050
The domestic equity benchmarks ended sharply lower on Friday, snapping a five-session winning streak. The Nifty slipped below the 24,050 mark as a steep sell-off in IT stocks weighed on sentiment. Technology shares came under pressure after Accenture trimmed its revenue growth guidance and flagged weak demand visibility, raising concerns about global IT spending. Healthcare and pharma stocks, however, bucked the broader weakness. Investor sentiment was further affected by continued FII selling, weak global cues and rising geopolitical tensions in the Middle East. Profit booking following the recent market rally also added to the downside pressure.